Evolving Clinical Paradigms for LDL Lowering: Focus on Efficacy, Implications, Side Effects, and Safety Results of Clinical Trials Evaluating PCSK9 Inhibition—Implications for the Patient with Diabetes - James M. McKenney, PharmD

Evolving Clinical Paradigms for LDL Lowering: Focus on Efficacy, Implications, Side Effects, and Safety Results of Clinical Trials Evaluating PCSK9 Inhibition—Implications for the Patient with Diabetes - James M. McKenney, PharmD


Published

June 27, 2016

Created by

CMEducation Resources symposium